GB201803298D0 - Dosage regime - Google Patents

Dosage regime

Info

Publication number
GB201803298D0
GB201803298D0 GBGB1803298.7A GB201803298A GB201803298D0 GB 201803298 D0 GB201803298 D0 GB 201803298D0 GB 201803298 A GB201803298 A GB 201803298A GB 201803298 D0 GB201803298 D0 GB 201803298D0
Authority
GB
United Kingdom
Prior art keywords
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1803298.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1803298.7A priority Critical patent/GB201803298D0/en
Publication of GB201803298D0 publication Critical patent/GB201803298D0/en
Priority to PCT/EP2018/065862 priority patent/WO2018229218A1/en
Priority to BR112019026498-1A priority patent/BR112019026498A2/en
Priority to EA202190040A priority patent/EA202190040A1/en
Priority to EP18732040.3A priority patent/EP3638372A1/en
Priority to CA3064681A priority patent/CA3064681A1/en
Priority to US16/622,663 priority patent/US11426467B2/en
Priority to MX2019014923A priority patent/MX2019014923A/en
Priority to JP2019569364A priority patent/JP2020523384A/en
Priority to KR1020207001219A priority patent/KR20200028950A/en
Priority to AU2018285455A priority patent/AU2018285455A1/en
Priority to US17/812,950 priority patent/US20230039868A1/en
Ceased legal-status Critical Current

Links

GBGB1803298.7A 2017-06-14 2018-02-28 Dosage regime Ceased GB201803298D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1803298.7A GB201803298D0 (en) 2018-02-28 2018-02-28 Dosage regime
AU2018285455A AU2018285455A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD25 ADC
EP18732040.3A EP3638372A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
BR112019026498-1A BR112019026498A2 (en) 2017-06-14 2018-06-14 dosing regimens for administration of an anti-cd25 adc
EA202190040A EA202190040A1 (en) 2018-02-28 2018-06-14 DOSING SCHEDULES FOR ADC K CD25 ADMINISTRATION
PCT/EP2018/065862 WO2018229218A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
CA3064681A CA3064681A1 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc
US16/622,663 US11426467B2 (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-CD25 ADC
MX2019014923A MX2019014923A (en) 2017-06-14 2018-06-14 Dosage regimes for the administration of an anti-cd25 adc.
JP2019569364A JP2020523384A (en) 2017-06-14 2018-06-14 Dosing regimen for administering anti-CD25 ADC
KR1020207001219A KR20200028950A (en) 2017-06-14 2018-06-14 Dosage regime for administration of anti-CD25 ADC
US17/812,950 US20230039868A1 (en) 2017-06-14 2022-07-15 Dosage regimes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1803298.7A GB201803298D0 (en) 2018-02-28 2018-02-28 Dosage regime

Publications (1)

Publication Number Publication Date
GB201803298D0 true GB201803298D0 (en) 2018-04-11

Family

ID=61903336

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1803298.7A Ceased GB201803298D0 (en) 2017-06-14 2018-02-28 Dosage regime

Country Status (2)

Country Link
EA (1) EA202190040A1 (en)
GB (1) GB201803298D0 (en)

Also Published As

Publication number Publication date
EA202190040A1 (en) 2021-03-30

Similar Documents

Publication Publication Date Title
IL276232A (en) Pharmaceutical compounds
GB2569961B (en) Pharmaceutical
GB2572126B (en) Pharmaceutical
GB2572125B (en) Pharmaceutical
GB201810245D0 (en) Pharmaceutical compounds
GB201713653D0 (en) Dosage regimen
IL275708A (en) G1t38 superior dosage regimes
IL283900A (en) Pharmaceutical combinations
GB201810239D0 (en) Pharmaceutical compounds
GB201819961D0 (en) Pharmaceutical compounds
IL277334A (en) Pharmaceutical combinations
GB201819960D0 (en) Pharmaceutical compounds
IL279334A (en) Pharmaceutical combinations
GB201801562D0 (en) Pharmaceutical compounds
GB201800378D0 (en) Pharmaceutical compounds
IL269169A (en) Novel dosage form
GB201816369D0 (en) Pharmaceutical compounds
GB201607548D0 (en) Solid dosage form
GB201812049D0 (en) Pesticidal dosage form
GB201808473D0 (en) Dosage regime
GB201808507D0 (en) Dosage Regime
GB201808101D0 (en) Dosage regime
GB201803298D0 (en) Dosage regime
GB201802679D0 (en) Dosage regime
GB201720544D0 (en) Dosage regime

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)